Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.816515
Abstract: Globally, human immunodeficiency virus type 1 (HIV-1) infection is a major health burden for which successful therapeutic options are still being investigated. Challenges facing current drugs that are part of the established life-long antiretroviral therapy… read more here.
Keywords: component hiv; targeting ccr5; ccr5 component; hiv ... See more keywords